← Leaderboards
Nancy Hutton
Johns Hopkins University
$259,033
Attributed
$259,033
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $100.1K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$259,033 · 6
By mechanism
M01$259,033 · 6
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Susan L Furth$36,670,372
- Laurie E Cutting$31,769,016
- Carole L Marcus$11,334,904
- Christopher B Forrest$16,974,265
- Deborah Persaud$30,632,571
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsQuality Of LifePerinatalHuman SubjectPathologic ProcessCombination ChemotherapyLongitudinal Human StudyHuman Therapy EvaluationClinical ResearchPediatric AidsAids TherapyOutcomes ResearchZidovudineClinical Trial Phase IEmbryo /Fetus ChemotherapyClinical TrialsChronicAnti-Retroviral AgentsChildrenData CollectionChildhoodAdolescent MedicineDatabasesCost Effective
Grant awards (9)
PACTG 219$33,164
M01 · FY2007 · RR · contact PI
ACTG 219$72,243
M01 · FY2006 · RR · contact PI
COGNITIVE, BEHAVIORAL AND PSYCHOSOCIAL CORRELATES OF MEDICATION ADHERENCE IN CHI$1,055
M01 · FY2006 · RR · contact PI
ACTG P1042S VERSION 10$1,055
M01 · FY2006 · RR · contact PI
ACTG 219$100,138
M01 · FY2005 · RR
ACTG 219$51,378
M01 · FY2004 · RR
ACTG 219--PEDIATRIC LATE OUTCOME HIV DISEASE PROGRESSION$0
M01 · FY2002 · RR
ACTG 219--PEDIATRIC LATE OUTCOME HIV DISEASE PROGRESSION$0
M01 · FY2001 · RR
ACTG 219--PEDIATRIC LATE OUTCOME HIV DISEASE PROGRESSION$0
M01 · FY2000 · RR